Revvity Inc (RVTY) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 05 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Revvity Inc  (NYSE: RVTY)


Revvity Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Revvity Inc's ROI in the second quarter of 2026?
Revvity Inc achieved a return on average invested assets (ROI) of 2.21 % in its second quarter of 2026, which is below Revvity Inc's average return on investment, which stands at 5.47%.

ROI has improved compared to 2.18% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 106 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2054 to 2092.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 05 2026)
II. Quarter		 (Apr 05 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Investment Change TTM -8.87 % -6.88 % -5 % -4.85 % -2.48 %
Y / Y Net Income Change TTM -16.71 % -16.37 % -1.3 % 58.61 % 415.17 %
Investment (TTM) in Millions 10,551 10,616 10,837 10,916 11,691
Return On Investment (TTM) 2.21 % 2.18 % 2.14 % 2.06 % 2.42 %
RVTY's Overall Ranking # 2092 # 2054 # 1643 # 1753 # 1396
Seq. Investment Change TTM -2.59 % -2.43 % -1.96 % -2.2 % -0.47 %
Seq. Net Income Change TTM -0.89 % -0.63 % 1.57 % -16.73 % -0.49 %
Net Income (TTM) in Millions 238 240 241 237 285

RVTY Company Profile >> Back to RVTY Roi Comparisons >> See Annual RVTY Return On Investment



Return On Investment RVTY's Ranking
Within: No.
Industry # 6
Sector # 107
Overall # 2092

Return On Investment Statistics
High Average Low
17.65 %
5.47 %
-1.24 %
(Jul 04 2021)   (Mar 31 2013)







Financial Statements
Revvity Inc's II. Quarter Investments $ 10,551 Millions RVTY's Balance sheet
Revvity Inc's II. Quarter Income $ 52 Millions Quarterly RVTY's Income Statement
RVTY's Income by Division See RVTY's Income by Division


RVTY Annual Return On Investment (Dec 28 2025)
2025		 (Dec 29 2024)
2024		 (Dec 31 2023)
2023		 (Jan 01 2023)
2022		 (Jan 02 2022)
2021
Total Investments in Millions 10,837 11,739 13,360 12,585 12,199
Y / Y Investment Growth -7.69 % -12.13 % 6.16 % 3.16 % 93.39 %
Net Income in Millions 241 270 693 569 943
Y / Y Net Income Growth -10.79 % -60.99 % 21.77 % -39.65 % 29.57 %
Annual Return On Investment 2.23 % 2.3 % 5.19 % 4.52 % 7.73 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 2.23 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RVTY's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RVTY's Competitors
Subscribers only: Roi for Revvity Inc's Suppliers
Subscribers only: Return On Investment for RVTY's Customers

Other Ratios
RVTY's Roa RVTY's Inventory Turnover Ratio RVTY's Growth Rates RVTY's Dividend Statistics
RVTY's Profitability Ratios RVTY's Asset Turnover Ratio RVTY's Dividend Growth
RVTY's Roe RVTY's Valuation Ratios RVTY's Financial Strength Ratios RVTY's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 05 2026, within Healthcare Sector ROI
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %

Date modified: 2026-09-26T07:19:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.